NCT02180373View on ClinicalTrials.gov

PREDICT-PVI Understanding Peripheral Restenosis: Genomic and Proteomic Determinants of Vascular Intervention

CompletedOBSERVATIONAL
Enrollment

67

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

July 28, 2017

Study Completion Date

July 28, 2017

Conditions
Peripheral Artery Disease
Trial Locations (4)

32611

University of Florida, Gainesville

94143

UCSF, San Francisco

98108

Puget Sound VA, Seattle

03766

Dartmouth Hitchcock Medical Center, Lebanon

All Listed Sponsors
lead

Vascular Cures

OTHER

NCT02180373 - PREDICT-PVI Understanding Peripheral Restenosis: Genomic and Proteomic Determinants of Vascular Intervention | Biotech Hunter | Biotech Hunter